BASF develops functional skin models using 3D biotechnology

BASF Care Creations, a unit of BASF Chemicals and CTI Biotech, has developed a 3D tissue model of human sebaceous glands that was presented at the NYSCC Cosmetics Congress to show the waxes secreted in the sebaceous glands (in most skin cells) Protective substances (sebum in the human body) produce and regulate the success of the active ingredient.

The study involved a 3D human sebaceous gland model using CTI Biotech, a research company that specializes in skin cosmetics, stem cells and cancer, recently installed a CELLINK BIO X 3D printer to develop a method of treatment for the latter. 3D human sebaceous gland technology creates and grows human sebaceous gland cell models that are bio-printed with custom and artificially layered skin cell models.

"The 3D model developed by CTI Biotech is more relevant to human physiology and sebaceous gland metabolism than the current in vitro experiments." Dr. Sabine Pain, Project Leader at BASF, said: 'Our understanding of sebaceous metabolism is to develop and test the skin for the skin Advanced cosmetic bioactives for care applications, especially for oily skin.
Dr. Nico Forraz, CTI Biotech's CEO, believes that the research announced at the NYSCC Cosmetics Conference is the key to validating the 'powerful technology in human skin care research' that will be used to study the role of sebaceous glands in skin diseases CTI Biotech is Development of a 3D bioprinter capable of implanting sebaceous tissue into the skin model.
Professor Colin McGuckin, Chief Scientific Officer and Chief Scientist at CTI Biotech, said: "Understanding the benefits of working with tissue engineering experts is due to BASF's experience and expertise in developing solutions for the cosmetics market. The next development of the sebaceous gland model will be based on 3D bio-printing technology , Enabling us to completely reproduce microglands in vitro and form a complete complexion model. "Last year, BASF and the French company Poietis signed a bioprint agreement to jointly develop BASF's 'mimeskin' artificial skin for cosmetic testing .
Article Source: 天工 社